TM
SCREEN OFTEN ISOLATE EARLY SLOW THE SPREAD
THE CDC AND WHO DESIGNATE
LOSS OF SMELL
AS A SYMPTOM OF COVID-19(1)
Three-Quarters of People with COVID-19 infection are Asymptomatic. (14)
Optimist Screening was designed and clinically validated to detect anosmia (loss of smell), an early indicator of Covid-19 infection in Asymptomatic carriers.
Asymptomatic Carriers or "Silent Spreaders" may experience no symptoms of infection other than loss of smell. (2)
​
Optimist Screening identifies approximately 73% of Covid-Positive
Asymptomatic persons by confirming loss of smell. (3)
​
Asymptomatic carriers are just as contagious as symptomatic carriers (4) and asymptomatics do not experience fever, so temperature scans are ineffective.
​
Acute loss of sense of smell needs to be considered globally as a criterion for self isolation, testing and contact tracing in order to contain the spread of COVID-19. (13)
Incorporating Optimist Screening into your organization's safety protocol initiative shows your employees that their health and ensuring a safe work environment are top priorities.
​
Daily screening helps to identify loss of smell in Asymptomatic carriers within businesses, manufacturing plants, hospitals, schools, senior living facilities, restaurants,
churches, airports and public-event venues.
​
Slowing the spread protects productivity and revenue.
OPTIMIST SCREENING MAKES DETECTION OF ANOSMIA IN ASYMPTOMATIC CARRIERS SIMPLE AND EASILY SCALABLE
"Smells like mint."
Optimist Screening requires no medical training to administer and just seconds to produce results.
Optimist utilizes pharmaceutical-grade metered dose components and dry-spray technology to dispense precise volumes of commonly recognized odorants onto a disposable test sheet. The test subject smells the sheet, then confirms the particular scent. If the test subject cannot confirm the scent, this may indicate loss of smell from infection. Scanning our QR code links the subject to information about the nearest Covid-19 testing site.
THE ONLY CLINICALLY VALIDATED ANOSMIA TEST FOR SCREENING AND IDENTIFING ASYMPTOMATIC CARRIERS.
SIMPLE IMPLEMENTATION
No medical training required.
FAST AND EFFICIENT
About 5 seconds to administer
and results are immediate.
​
NON-INVASIVE
No throat or nose swabs.
CONTACT-LESS
No person-to-person contact.
​
METERED-DOSE PRECISION
Dispenses an exact amount of
odorant for consistent screening method.
DRY-SPRAY TECHNOLOGY
No wetting of test material.
​
PRESSURIZED CONTAINER
Does not draw particulates back into the device.
​
ROTATION OF ODORANTS
3 unique scents per kit, like orange, mint, and garlic to enable confirmation.
5
seconds
Optimist Screening takes only five seconds to complete and produces immediate results.
560
tests per kit
A large quantity of tests per kit makes Optimist Screening easily scalable.
